Presentation is loading. Please wait.

Presentation is loading. Please wait.

Phillip G. Rowse, MD, Dawn E

Published byMarianna Summers Modified over 5 years ago

Similar presentations

Presentation on theme: "Phillip G. Rowse, MD, Dawn E"— Presentation transcript:

1 Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer 
Phillip G. Rowse, MD, Dawn E. Jaroszewski, MD, Mathew Thomas, MD, Kristi Harold, MD, William S. Harmsen, MS, K. Robert Shen, MD  The Annals of Thoracic Surgery  Volume 104, Issue 4, Pages (October 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival between men and women.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Recurrence-free survival between men and women.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Recurrence-free survival based on pathologic response to neoadjuvant chemoradiotherapy (nCRT). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Phillip G. Rowse, MD, Dawn E"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Giant Transdiaphragmatic Intercostal Hernia

Giant Transdiaphragmatic Intercostal Hernia
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer  Yoichi.

Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer  Yoichi.
MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction Chemoradiotherapy  Michael Augustine Ko, MD, PhD, Guan Zehong, MS, Carl.

MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction Chemoradiotherapy  Michael Augustine Ko, MD, PhD, Guan Zehong, MS, Carl.
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Diaphragmatic Defect Complicating Peritoneal Dialysis

Diaphragmatic Defect Complicating Peritoneal Dialysis
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation  Matthew L. Williams, MD,

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation  Matthew L. Williams, MD,
Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer  Talha Shaikh,

Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer  Talha Shaikh,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.

Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
H. Volkan Kara, MD, MS, Jeffrey Javidfar, MD, Thomas A. D’Amico, MD 

H. Volkan Kara, MD, MS, Jeffrey Javidfar, MD, Thomas A. D’Amico, MD 
Castigliano M. Bhamidipati, DO, MS, George J

Castigliano M. Bhamidipati, DO, MS, George J
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Similar presentations

Ads by Google